ERNA vs FOX · P/E 0.0, rev $582.0K vs P/E 13, rev $16.30B
Eterna Therapeutics Inc (ERNA) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the ERNA and FOX stock pages for the full models.
Not investment advice.